Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3736161014 | Product containing only varicella-zoster virus antibody (medicinal product) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3736162019 | Varicella-zoster virus antibody only product | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| 3782542019 | Product containing only Varicella-zoster virus antibody (medicinal product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 2864021000001119 | Varicella immunoglobulin (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2864041000001112 | Varicella immunoglobulin | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Varicella immunoglobulin | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Varicella immunoglobulin | Is a | Product containing Varicella-zoster virus antibody (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Varicella immunoglobulin | Has active ingredient | Varicella-zoster virus antibody | true | Inferred relationship | Existential restriction modifier | 1 | |
| Varicella immunoglobulin | Plays role | Passive immunity stimulant therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Varicella immunoglobulin | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only Varicella-zoster virus antibody in parenteral dose form (medicinal product form) | Is a | True | Varicella immunoglobulin | Inferred relationship | Existential restriction modifier | |
| Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | True | Varicella immunoglobulin | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR